Published in Medical Verdicts and Law Weekly, December 28th, 2006
As part of the settlement, the company said it expects to make a payment in the fourth quarter of 2006 of approximately $80 million representing taxes and interest owed under the settlement.
The company expects the settlement announced will not have a material impact on income from continuing or discontinued operations after taking into account the impact of the deferred tax valuation allowance.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly